{"id":"W4391589947","doi":"10.1016/j.ygyno.2024.01.021","title":"Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Medicine; Nausea; Quality of life (healthcare); Placebo; Constipation; Internal medicine; Vomiting; Ovarian cancer; Cancer; Randomized controlled trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002994972,0.0004649981,0.002919504,0.0002188001,0.0001317366,0.0000231202,0.0002499944,0.0004689183,0.000834035],"category_scores_gemma":[0.003276315,0.0002619964,0.0002105943,0.0009428709,0.0007172509,0.0001421184,0.00004694751,0.0008692087,0.00001676087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00149311,"about_ca_system_score_gemma":0.003225202,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007968978,"about_ca_topic_score_gemma":0.00589733,"domain_scores_codex":[0.9926032,0.003000127,0.002294935,0.0009112611,0.0005291739,0.0006613199],"domain_scores_gemma":[0.9838484,0.01367678,0.001270064,0.0006519604,0.0002721442,0.0002806288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9615347,0.002522796,0.008779331,0.00006567969,0.0009176027,0.00009475654,0.001949129,0.0004185949,0.00006058641,0.0002367395,0.002951415,0.02046867],"study_design_scores_gemma":[0.9420264,0.01325342,0.04037027,0.0003914651,0.0002835093,0.000003108376,0.0001920419,0.0002862095,0.00006285308,0.0003352148,0.002497699,0.0002977506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734125,0.001515956,0.0001730819,0.01344134,0.0009334874,0.008432369,0.0008013233,0.0002185325,0.001071418],"genre_scores_gemma":[0.9920906,0.000457649,0.0009889517,0.003135904,0.0001672112,0.00213105,0.0007958147,0.00005563072,0.0001772295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03159094,"threshold_uncertainty_score":0.9999833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03742922405848668,"score_gpt":0.3674416813460257,"score_spread":0.330012457287539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}